We are live on ! Find out more
HURA

TuHURA Biosciences

70 hedge funds and large institutions have $15.2M invested in TuHURA Biosciences in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 5

40% more funds holding

Funds holding: 5070 (+20)

25% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 12

7% more capital invested

Capital invested by funds: $14.2M → $15.2M (+$928K)

14.63% less ownership

Funds ownership: 14.63%0% (-15%)

Holders
70
Holders Change
+20
Holders Change %
+40%
% of All Funds
0.92%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
15
Reduced
12
Closed
5
Calls
Puts
Net Calls
Net Calls Change

HURA Hedge Fund Activity: Q3 2025 in Review

70 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q3 2025, worth a combined $15.2M — up 6.5% from $14.2M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new HURA positions and 5 closed out — a net gain of 20 holders — while 15 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock, adding an estimated $484K. The largest seller was Fifth Third Bancorp, exiting entirely with an estimated $1.06M sold.

  • 70 institutional investors held TuHURA Biosciences (HURA) as of Q3 2025, up from 50 in Q2 2025.
  • Funds reported $15.2M of TuHURA Biosciences stock for Q3 2025, up 6.5% quarter-over-quarter.
  • 25 funds opened new TuHURA Biosciences positions in Q3 2025 and 5 closed out, a net change of +20 holders.
  • The largest TuHURA Biosciences buyer in Q3 2025 was BlackRock, an estimated $484K added.
  • The largest TuHURA Biosciences seller in Q3 2025 was Fifth Third Bancorp, an estimated $1.06M sold.

Based on aggregated 13F filings for Q3 2025.